It is not known whether a prophylactic antibiotic administered prior to surgery reaches adequate levels in the peritoneum, where peritonitis may take place. This study determined levels of cefmenoxime in sera and peritoneal tissues of patients undergoing gastrointestinal surgery. Fifteen patients who underwent elective gastrointestinal surgery received an intravenous drip infusion of cefmenoxime (2 g) over 1 h prior to surgery. In patients who underwent gastrectomy, the level of cefmenoxime in serum was 130.8 6.9 ,Lg/ml at laparotomy and decreased to 5.0 + 0.7 ;Lg/ml at 4 h. Levels in parietal peritoneal and omental tissues at laparotomy were 35.3 + 5.2 and 19.2 3.5 tag, respectively, and decreased time dependently. In patients who underwent cholecystectomy, the level of cefmenoxime in serum was 137.9 + 7.3 pg/ml at laparotomy and decreased to 5.0 + 1.2 ,ug/ml at 4 h. Levels in parietal peritoneal and omental tissues were 31.0 8.4 and 13.7 + 3.3 ,ug/g, respectively, and decreased time dependently. The level of cefmenoxime in serum correlated with the levels of cefmenoxime in parietal peritoneum (r = 0.64, P < 0.01) and in omentum (r = 0.47, P < 0.02). In patients with appendicitis who received a bolus injection of 2 g of cefmenoxime, the level of drug in inflammatory omental tissue correlated with the level in serum. The levels in peritoneal tissue during surgery lasting up to 2 h were significantly greater than in MIC of cefmenoxime against almost all bacteria reported. A preoperative single dose of 2 g of cefmenoxime probably is effective as a prophylactic for intraoperative contamination.
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Prophylactic antibiotics are widely used prior to or during elective gastrointestinal surgery, and the importance of the prophylactic antibiotics in reducing postoperative infections has been demonstrated (3, 4, 10) . The aim of a prophylactic administration is to prevent wound infection and peritonitis, both of which may be caused by intraoperative contamination. The basic concept underlying the effective use of prophylactic antibiotics to prevent infectious complications in surgical patients is that an adequate amount of an appropriate antibiotic must be present in the tissue before or during a bacterial challenge (1). The concept has been confirmed and accepted in human studies (4, 10) . Further, this concept probably applies to the therapeutic use of antibiotics which are given to patients perioperatively and after surgical drainage for peritonitis or intra-abdominal abscess. However, there is no information on whether the levels of antibiotics are sufficient to be effective in peritoneal tissue, where peritonitis may occur. Therefore, in practice, the use of antibiotics has been based mainly on the experience of each practitioner and on studies with experimental animal models. The current study was conducted during gastrointestinal surgery to determine levels in peritoneal tissue of cefmenoxime given prior to surgery. Cefmenoxime is a semisynthetic cephalosporin with a broad spectrum of activity against many gram-positive and gram-negative bacteria and excellent P-lactamase stability (8, 9) . The current study also examined levels of cefmenoxime in serum and compared them with levels in peritoneal tissue.
MATERIALS AND METHODS
The protocol of the study was approved by the Institutional Ethical Committee for Research in Human Subjects (Kyoto University Hospital and Nagahama Red Cross Hospital). Only patients from whom an informed written consent had been obtained were included in the study. Those polynomial regression by using the following equation: y = a + bx + cx2, where x is the logarithm of the concentration of the standards (1.25, 2.5, 5.0, 10.0, 20.0, and 40.0 ,ug/ml) and y is the corresponding mean zone diameter. High-concentration samples were diluted with normal serum so that the resulting zone sizes were within the range of the standard curve concentrations. The sensitivity of the method was 0.5 ,ug/ml in serum. The coefficients of variation (including day-to-day variation) were 10.0% at 2.5 ,ug/ml and 9.8% at 20
,ug/ml. plus choledochotomy in 4 patients. The patients showed no evidence for intra-abdominal infection before surgery as assessed by leukocyte count and abdominal computerized tomography findings, which were confirmed at surgery.
In patients who underwent gastrectomy (Fig. 1) , the level of cefmenoxime in serum was 130.8 ± 6.9 ,ug/ml at laparotomy and declined gradually to 38.8 ± 3.7 ,ug/ml at 1 h, 21.5 + 3.2 ,ug/ml at 2 h, and 5.0 + 0.7 jig/ml at 4 h. Levels in parietal peritoneal and omental tissue were 35.3 + 5.2 and 19.2 + 3.5 ,g/g, respectively, at laparotomy and decreased time dependently.
In patients who underwent biliary tract surgery (Fig. 2) , the level of cefmenoxime in serum was 137.9 ± 7.3 ,g/ml at laparotomy and declined gradually to 32.4 ± 3.7 ,g/ml at 1 h, 10.0 ± 0.3 ,ug/ml at 2 h, and 5.0 _ 1.2 ,g/ml at 4 h. Levels in parietal peritoneal and omental tissue were 31.0 + 8.4 and 13.7 ± 3.3 ,ug/g, respectively, and decreased time dependently.
In patients who received drip infusion of 2 g of cefmenoxime, levels of cefmenoxime in serum correlated with both the parietal peritoneal level (r = 0.64, P < 0.01) and the omental level (r = 0.47, P < 0.02) of cefmenoxime (Fig. 3) . The tissue/serum ratios were 24.9% ± 3.3% for parietal peritoneum and 12.7% ± 2.0% for omentum at laparotomy. These ratios increased slightly at 1 h to 33.1% ± 3.5% for parietal peritoneum and 21.7% ± 4.4% for omentum. No postoperative infection was observed in these patients.
Study 2. Eight patients were included in the study (five males and three females; age, 43.8 ± 4.7 years; body weight, 59.9 ± 2.6 kg). The patients showed signs of appendicitis and had a mean leukocyte count of 12,800 ± 1,640/mm3. Levels of cefmenoxime in serum and omentum are shown as a function of time in Fig. 4 . The level of drug in inflammatory omentum tissue correlated with the level in serum, and both declined time dependently. No postoperative infection was observed in these patients. 
DISCUSSION
Levels of cefmenoxime in serum and peritoneal tissue were studied during abdominal surgery in humans following the administration of drug by a drip infusion or a bolus injection. The results of our study showed that the levels of antibiotic in parietal peritoneum and omentum during gastrointestinal surgery correlated highly with the level in serum. At laparotomy following a drip infusion of 2 g of cefmenoxime, the tissue/serum ratio was 25% for parietal peritoneum and 13% for omentum. The ratios increased slightly 1 h after dosing. The level in omental tissue was lower than that in parietal peritoneum, probably because omental tissue contains more fat, suggesting that disposition of an antibiotic to adipose tissue may be relatively lower than that to parietal peritoneum. These data are important, because for an antibiotic to be effective as a prophylactic agent, it should be present at the site of infection before bacterial contamination occurs.
In patients with appendicitis, cefmenoxime was administered by an intravenous bolus injection. By this method, the peak concentration in serum may occur just after the injection and decline gradually thereafter. On the other hand, the level in omental tissue should increase after injection and attain a peak after that of the level in serum. Of interest, however, within the range of the current study, the timerelated phase of the level in omental tissue was similar to that of the level in serum and the two correlated with each other, suggesting that the disposition of cefmenoxime to peritoneal tissues might be rapid. The current results demonstrated that by either a drip infusion or a bolus injection, the level of drug in peritoneal tissue correlated highly with the level in serum. Thus, the first goal of antibiotic administration can be to achieve a high level in serum. It has been reported that the MIC of cefmenoxime was under 1 ,ug/ml against almost all bacteria isolated from patients with clinical infections (5, 7) . The current study demonstrated that levels in peritoneal tissue during surgery were greater than 1 ,ug/ml for up to 2 h. Concentrations in tissue homogenate represent a mixture of levels in intracellular and interstitial fluids, and tissue homogenates underestimate the concentrations of P-lactams because of poor intracellular penetration. Thus, the actual levels of antibiotic in interstitial fluids might be higher than the values obtained in this study. From this point of view, a preoperative single dose of cefmenoxime (2 g, either by a drip infusion or by a bolus injection) probably is effective as a prophylactic against intraoperative contamination. However, for postoperative infectious complication, the duration of the surgical procedure has been cited as another important factor. Kaiser et al. (6) reported more infectious complications in patients with operations exceeding 4 h. The current results showed that the levels of drug in tissue exceeded MICs for up to 2 h but declined time dependently. Thus, physicians may have to consider an additional dose of an intraoperative antibiotic with longer surgical procedures.
In summary, the levels of cefmenoxime in peritoneal tissue were sufficient as a prophylactic during surgery of up to 2 h when the drug was administered prior to surgery. The levels in cefmenoxime in tissue correlated highly with the levels in serum. Thus, it is most likely unnecessary to monitor levels of drug in tissue. The optimal use and timing of prophylactic antibiotics may reduce the number of postoperative infections induced by contamination during surgery.
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